In the News
APRIL 13, 2020
MiraKind.org announces $50,000 donation from George and Loretta Whitesides for COVID-19 Testing at Los Angeles-area Skilled Nursing and Senior Care Facilities
Mirakind.org, a non-profit organization dedicated to enabling individuals to make informed healthcare decisions based on their personal genetics, today announced that it has received a $50,000 donation from George and Loretta Whitesides to fund COVID-19 testing for healthcare providers and staff, as well as new and at-risk residents, at nursing and senior care facilities in the Los Angeles area.
“We are very grateful for the generous contribution from George and Loretta,” said Joanne Weidhaas, MD, PhD, MSM, co-founder of MiraDx and founder of MiraKind.org. “There remains tremendous need for fast, accurate testing of healthcare providers and other frontline workers who continue to make enormous sacrifices to protect the most vulnerable individuals in this pandemic, and specifically at nursing homes and other care facilities that have been particularly susceptible to widespread transmission of the virus.”
APRIL 3, 2020
MiraDx Creates COVID-19 Tests for Nursing Homes, Cops, Firefighters & Healthcare Workers
When Dr. Joanne Weidhaas lost their family's orange Tabby cat named Pumpkin, to a "weird coronavirus" three years ago, the RNA biologist threw herself into a month-long study of it. She wanted to get to the bottom of what had happened.
So once this novel coronavirus pandemic hit, Weidhaas realized she was strangely well-equipped for research and testing.
"This (new coronavirus) comes along and, I mean, we've done all the research on it, and I sit down with the head of my lab (and) we just said 'we can actually really do that,'" Weidhaas said. "We have all the equipment, we have the expertise, we're a high-complexity molecular diagnostics lab, which is exactly poised to look at this."
APRIL 1, 2020
Los Angeles-based Molecular Genetics Company MiraDx Transitions CLIA-Certified Lab to Provide COVID-19 Testing to Essential
WorkersMiraDx, a Los Angeles-based molecular genetics company, has transitioned its CLIA-certified lab to provide COVID-19 tests for essential workers, prioritizing hospital and field-based healthcare workers who are providing direct patient care as well as first responders. In addition, MiraDx’s sister non-profit organization, MiraKind.org, is distributing the tests free of charge to frontline workers and organizations in need via philanthropic donations.
MiraDx currently has the capacity to analyze 3,000 tests per day and will be scaling up in the coming weeks to over 10,000 tests per day. MiraDx has no backlog. Test results will be available within 24-48 hours of receipt of the sample at MiraDx’s laboratory. MiraDx is making tests available for approximately $150 per completed test.